Published in Cancer Res on November 15, 2003
New technologies for human cancer imaging. J Clin Oncol (2008) 3.46
New strategies for fluorescent probe design in medical diagnostic imaging. Chem Rev (2010) 3.35
Subcellular-resolution molecular imaging within living tissue by fiber microendoscopy. Opt Express (2007) 3.01
Optical contrast agents and imaging systems for detection and diagnosis of cancer. Int J Cancer (2008) 2.72
High-resolution imaging in Barrett's esophagus: a novel, low-cost endoscopic microscope. Gastrointest Endosc (2008) 2.51
A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signals. Nat Mater (2013) 2.32
Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance. Neoplasia (2010) 2.21
Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions. Ann Surg Oncol (2009) 2.02
Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. Bioconjug Chem (2005) 2.01
Molecular imaging with optics: primer and case for near-infrared fluorescence techniques in personalized medicine. J Biomed Opt (2008) 1.94
Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small (2009) 1.93
Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice. Bioconjug Chem (2006) 1.75
Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging. Acta Radiol (2009) 1.49
Hyaluronidase expression induces prostate tumor metastasis in an orthotopic mouse model. Am J Pathol (2006) 1.45
Institutional shared resources and translational cancer research. J Transl Med (2009) 1.41
Near-infrared fluorescence labeled anti-TAG-72 monoclonal antibodies for tumor imaging in colorectal cancer xenograft mice. Mol Pharm (2009) 1.38
Long-circulating near-infrared fluorescence core-cross-linked polymeric micelles: synthesis, characterization, and dual nuclear/optical imaging. Biomacromolecules (2007) 1.28
Exogenous Molecular Probes for Targeted Imaging in Cancer: Focus on Multi-modal Imaging. Cancers (Basel) (2010) 1.24
Multimodality imaging of the HER-kinase axis in cancer. Eur J Nucl Med Mol Imaging (2007) 1.23
Dynamic near-infrared optical imaging of 2-deoxyglucose uptake by intracranial glioma of athymic mice. PLoS One (2009) 1.18
Advances in molecular imaging: targeted optical contrast agents for cancer diagnostics. Nanomedicine (Lond) (2012) 1.17
Discrimination of benign and neoplastic mucosa with a high-resolution microendoscope (HRME) in head and neck cancer. Ann Surg Oncol (2012) 1.11
Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions. Integr Biol (Camb) (2013) 1.10
Discovery of targeting ligands for breast cancer cells using the one-bead one-compound combinatorial method. J Med Chem (2009) 1.10
Clinical implications of near-infrared fluorescence imaging in cancer. Future Oncol (2009) 1.07
Current and future clinical applications for optical imaging of cancer: from intraoperative surgical guidance to cancer screening. Semin Oncol (2011) 1.07
Fluorescent fructose derivatives for imaging breast cancer cells. Bioconjug Chem (2007) 1.05
In vivo imaging of xenograft tumors using an epidermal growth factor receptor-specific affibody molecule labeled with a near-infrared fluorophore. Neoplasia (2010) 1.04
Experimental measurement of time-dependent photon scatter for diffuse optical tomography. J Biomed Opt (2011) 0.99
Multicolor fluorescent intravital live microscopy (FILM) for surgical tumor resection in a mouse xenograft model. PLoS One (2009) 0.99
uPAR-targeted optical imaging contrasts as theranostic agents for tumor margin detection. Theranostics (2013) 0.98
Purification method directly influences effectiveness of an epidermal growth factor-coupled targeting agent for noninvasive tumor detection in mice. Anal Biochem (2006) 0.94
Optical imaging of the breast. Cancer Imaging (2008) 0.93
Targeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptide. Mol Imaging Biol (2009) 0.91
Self-assembled gold nanoparticle molecular probes for detecting proteolytic activity in vivo. ACS Nano (2010) 0.90
In vivo tomographic imaging with fluorescence and MRI using tumor-targeted dual-labeled nanoparticles. Int J Nanomedicine (2013) 0.90
Targeted molecular imaging in oncology: focus on radiation therapy. Semin Radiat Oncol (2008) 0.89
PET of EGFR expression with an 18F-labeled affibody molecule. J Nucl Med (2012) 0.89
Selective targeting of antibody conjugated multifunctional nanoclusters (nanoroses) to epidermal growth factor receptors in cancer cells. Langmuir (2011) 0.89
Near-infrared molecular imaging of tumors via chemokine receptors CXCR4 and CXCR7. Clin Exp Metastasis (2011) 0.88
Near-infrared molecular probes for in vivo imaging. Curr Protoc Cytom (2012) 0.88
Dual-wavelength imaging of tumor progression by activatable and targeting near-infrared fluorescent probes in a bioluminescent breast cancer model. PLoS One (2012) 0.88
Targeted noninvasive imaging of EGFR-expressing orthotopic pancreatic cancer using multispectral optoacoustic tomography. Cancer Res (2014) 0.87
Optical imaging in breast cancer diagnosis: the next evolution. J Oncol (2012) 0.86
Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer. Int J Nanomedicine (2012) 0.86
Fluorescence molecular tomography: principles and potential for pharmaceutical research. Pharmaceutics (2011) 0.86
Small-molecule fluorophores and fluorescent probes for bioimaging. Pflugers Arch (2013) 0.85
Molecular imaging probes for diagnosis and therapy evaluation of breast cancer. Int J Biomed Imaging (2013) 0.84
Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool. Transl Oncol (2011) 0.84
Delivery of optical contrast agents using Triton-X100, part 2: enhanced mucosal permeation for the detection of cancer biomarkers. J Biomed Opt (2009) 0.83
Rapid optical imaging of EGF receptor expression with a single-chain antibody SNAP-tag fusion protein. Eur J Nucl Med Mol Imaging (2010) 0.83
A comparative study of affibody, panitumumab, and EGF for near-infrared fluorescence imaging of EGFR- and EGFRvIII-expressing tumors. Cancer Biol Ther (2013) 0.82
Bio-imaging of colorectal cancer models using near infrared labeled epidermal growth factor. PLoS One (2012) 0.82
Detection of vascular endothelial growth factor in colon cancer xenografts using bevacizumab based near infrared fluorophore conjugate. J Biomed Sci (2014) 0.81
Quantum dot loaded immunomicelles for tumor imaging. BMC Med Imaging (2010) 0.81
Optical imaging probes in oncology. Oncotarget (2016) 0.81
In vivo fluorescent optical imaging of cytotoxic T lymphocyte migration using IRDye800CW near-infrared dye. Appl Opt (2008) 0.81
Near infrared planar tumor imaging and quantification using nanosized Alexa 750-labeled phospholipid micelles. Int J Nanomedicine (2009) 0.80
The noninvasive, quantitative, in vivo assessment of adenoviral-mediated gene delivery in skin wound biomaterials. Biomaterials (2009) 0.80
Exogenous near-infrared fluorophores and their applications in cancer diagnosis: biological and clinical perspectives. Expert Opin Med Diagn (2011) 0.80
Feasibility of transoral robotic-assisted high-resolution microendoscopic imaging of oropharyngeal squamous cell carcinoma. Head Neck (2015) 0.78
Optical tecnology developments in biomedicine: history, current and future. Transl Med UniSa (2011) 0.77
Near infrared optical visualization of epidermal growth factor receptors levels in COLO205 colorectal cell line, orthotopic tumor in mice and human biopsies. Int J Mol Sci (2013) 0.77
Near infrared imaging of EGFR of oral squamous cell carcinoma in mice administered arsenic trioxide. PLoS One (2012) 0.76
In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft. Photoacoustics (2016) 0.75
Comparison of several linear fluorophore- and quencher-conjugated oligomer duplexes for stability, fluorescence quenching, and kinetics in vitro and in vivo in mice. Bioconjug Chem (2007) 0.75
Surface biotinylation of cytotoxic T lymphocytes for in vivo tracking of tumor immunotherapy in murine models. Cancer Immunol Immunother (2016) 0.75
Prolactin Receptor-Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity. Cancer Res (2017) 0.75
A Transistor-like pH Nanoprobe for Tumour Detection and Image-guided Surgery. Nat Biomed Eng (2016) 0.75
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet (2009) 8.44
Genetic determinants of response to warfarin during initial anticoagulation. N Engl J Med (2008) 7.13
Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet (2010) 4.65
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol (2008) 4.34
Comparison of CT methods for determining the fat content of the liver. AJR Am J Roentgenol (2007) 3.45
Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr Opin Chem Biol (2002) 3.31
Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer. J Biomed Opt (2007) 3.04
Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. Cancer Res (2013) 2.98
Meta-analysis identifies common variants associated with body mass index in east Asians. Nat Genet (2012) 2.70
Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J Exp Med (2009) 2.63
Flexible graphene films via the filtration of water-soluble noncovalent functionalized graphene sheets. J Am Chem Soc (2008) 2.62
Identification of new genetic risk variants for type 2 diabetes. PLoS Genet (2010) 2.62
Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol (2009) 2.61
Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b. J Clin Oncol (2008) 2.53
Near-Infrared Fluorescence Imaging in Humans with Indocyanine Green: A Review and Update. Open Surg Oncol J (2010) 2.50
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. Proc Natl Acad Sci U S A (2013) 2.49
A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. Diabetes (2004) 2.46
Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet (2005) 2.44
Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes (2004) 2.43
In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy. Mol Cancer Ther (2008) 2.34
Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin Cancer Res (2009) 2.22
Dual-labeled trastuzumab-based imaging agent for the detection of human epidermal growth factor receptor 2 overexpression in breast cancer. J Nucl Med (2007) 2.16
Self-assembled graphene hydrogel via a one-step hydrothermal process. ACS Nano (2010) 2.13
Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials (2009) 2.13
Genetic association analysis using data from triads and unrelated subjects. Am J Hum Genet (2005) 2.06
A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J Am Chem Soc (2010) 2.02
Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators. Cancer (2012) 2.01
Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats. Mol Imaging Biol (2010) 2.00
New horizons for imaging lymphatic function. Ann N Y Acad Sci (2008) 2.00
Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl Med Biol (2006) 1.98
Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet (2010) 1.98
Quantitative imaging of lymph function. Am J Physiol Heart Circ Physiol (2007) 1.96
Noninvasive quantitative imaging of lymph function in mice. Lymphat Res Biol (2007) 1.96
Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet (2012) 1.91
Evaluation of 11 breast cancer susceptibility loci in African-American women. Cancer Epidemiol Biomarkers Prev (2009) 1.90
Evaluation of coverage variation of SNP chips for genome-wide association studies. Eur J Hum Genet (2008) 1.89
Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol Biomarkers Prev (2010) 1.87
LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol (2010) 1.85
Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. ACS Nano (2010) 1.78
Tumor margin detection using quantitative NIRF molecular imaging targeting EpCAM validated by far red gene reporter iRFP. Mol Imaging Biol (2013) 1.77
Recurrent tissue-specific mtDNA mutations are common in humans. PLoS Genet (2013) 1.77
Exome sequencing generates high quality data in non-target regions. BMC Genomics (2012) 1.72
Design, synthesis and biological evaluation of a novel class of anticancer agents: anthracenylisoxazole lexitropsin conjugates. Bioorg Med Chem (2008) 1.71
CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest (2011) 1.71
Quality analysis of in vivo near-infrared fluorescence and conventional gamma images acquired using a dual-labeled tumor-targeting probe. J Biomed Opt (2005) 1.70
Photoacoustic imaging of living mouse brain vasculature using hollow gold nanospheres. Biomaterials (2009) 1.70
Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. Blood (2010) 1.69
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy. Vaccine (2009) 1.68
Haemodynamics-driven developmental pruning of brain vasculature in zebrafish. PLoS Biol (2012) 1.65
Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc Res (2011) 1.65
Near-infrared optical imaging of integrin alphavbeta3 in human tumor xenografts. Mol Imaging (2004) 1.64
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer (2004) 1.62
Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability. Int J Radiat Oncol Biol Phys (2003) 1.62
Receptor-mediated transcytosis: a mechanism for active extravascular transport of nanoparticles in solid tumors. J Control Release (2012) 1.61
Genetic evidence implicating multiple genes in the MET receptor tyrosine kinase pathway in autism spectrum disorder. Autism Res (2008) 1.61
Tumor site-specific silencing of NF-kappaB p65 by targeted hollow gold nanosphere-mediated photothermal transfection. Cancer Res (2010) 1.60
First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent. J Am Chem Soc (2003) 1.59
Three-dimensional fluorescence lifetime tomography. Med Phys (2005) 1.59
Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry. Cancer Res (2011) 1.59
Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet (2011) 1.55
Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model. Radiology (2005) 1.55
Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib. Radiographics (2006) 1.54
Human Lymphatic Architecture and Dynamic Transport Imaged Using Near-infrared Fluorescence. Transl Oncol (2010) 1.53
Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol (2006) 1.52
miR-129 regulates cell proliferation by downregulating Cdk6 expression. Cell Cycle (2010) 1.51
Near-infrared fluorescence optical imaging and tomography. Dis Markers (2004) 1.51
Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. J Natl Cancer Inst (2010) 1.51
The age-dependent effect of anisometropia magnitude on anisometropic amblyopia severity. J AAPOS (2007) 1.50
Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. Acc Chem Res (2011) 1.48
Fluorescence-enhanced optical imaging in large tissue volumes using a gain-modulated ICCD camera. Phys Med Biol (2003) 1.47
Imaging in the diagnosis, staging, and follow-up of colorectal cancer. AJR Am J Roentgenol (2002) 1.47
Functional lymphatic imaging in tumor-bearing mice. J Immunol Methods (2010) 1.45
Effects of photoacoustic imaging and photothermal ablation therapy mediated by targeted hollow gold nanospheres in an orthotopic mouse xenograft model of glioma. Cancer Res (2011) 1.45
ATOM: a powerful gene-based association test by combining optimally weighted markers. Bioinformatics (2008) 1.44
Ultrahigh-rate supercapacitors based on eletrochemically reduced graphene oxide for ac line-filtering. Sci Rep (2012) 1.44
Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys (2002) 1.44
Genome-wide and Ordered-Subset linkage analyses provide support for autism loci on 17q and 19p with evidence of phenotypic and interlocus genetic correlates. BMC Med Genet (2005) 1.44
Adjustment for local ancestry in genetic association analysis of admixed populations. Bioinformatics (2010) 1.44
Polymer-drug conjugates: recent development in clinical oncology. Adv Drug Deliv Rev (2008) 1.43
Copper sulfide nanoparticles for photothermal ablation of tumor cells. Nanomedicine (Lond) (2010) 1.42
Remission of rheumatoid arthritis and potential determinants: a national multi-center cross-sectional survey. Clin Rheumatol (2014) 1.41
Controlled scalable synthesis of uniform, high-quality monolayer and few-layer MoS2 films. Sci Rep (2013) 1.41
Phase I study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol (2002) 1.41
Assessment of lymphatic contractile function after manual lymphatic drainage using near-infrared fluorescence imaging. Arch Phys Med Rehabil (2011) 1.40
Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. J Clin Oncol (2002) 1.40
Long-term follow-up of patients with giant cell tumor of the sacrum treated with selective arterial embolization. Cancer (2002) 1.39
National survey of knowledge, attitude and practice of fibromyalgia among rheumatologists in China. Int J Rheum Dis (2013) 1.39
Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls. Hum Mol Genet (2013) 1.38
First-time failure rates of candidates for board certification: an educational outcome measure. Arch Ophthalmol (2008) 1.37